|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000091723 |
| 005 |
20200518.0 |
| 008 |
170810s2015 nju eng |
| 020 |
|
|
|a 1118455207
|
| 020 |
|
|
|a 9781118455203
|
| 040 |
|
|
|a UniSZA
|e rda
|
| 050 |
0 |
0 |
|a RM301.5
|b .P43 2015
|
| 060 |
1 |
0 |
|a QV 778
|b .P536 2015
|
| 090 |
0 |
0 |
|a RM301.5
|b .P43 2015
|
| 245 |
1 |
0 |
|a Pharmaceutical amorphous solid dispersions
|c edited by Ann Newman
|
| 264 |
|
1 |
|a Hoboken, New Jersey :
|b Wiley
|c c2015
|
| 300 |
|
|
|a xiii, 488 pages :
|b illustration ;
|c 25 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. Introduction to amorphous solid dispersions -- 2. Polymers and surfactants -- 3. Amorphous solid dispersion screening -- 4. Solid state characterization of amorphous dispersions -- 5.
Physical stability and crystallization inhibition -- 6. Solubility and dissolution considerations for amorphous solid dispersions -- 7. Translational development of amorphous dispersions -- 8.
Preclinical and clinical studies -- 9. Spray-drying and scale-up -- 10. Hot melt extrusion of amorphous solid dispersions -- 11. Formulation development of amorphous dispersions -- 12. Scientific and regulatory considerations in product development -- 13. Chapter patenting amorphous solid dispersions of pharmaceuticals -- 14. Monographs on polymers and surfactants
|
| 650 |
|
0 |
|a Absorption
|
| 650 |
|
0 |
|a Drug Carrier
|x Pharmacokinetics
|
| 650 |
|
0 |
|a Drug delivery systems
|
| 650 |
|
0 |
|a Drugs
|x Bioavailability
|
| 650 |
|
0 |
|a Drugs
|x Solubility
|
| 650 |
|
0 |
|a Pharmacokinetics
|
| 650 |
|
0 |
|a Polymers
|x Chemistry
|
| 650 |
|
0 |
|a Polymers
|x Pharmacokinetics
|
| 650 |
|
0 |
|a Solubility
|
| 650 |
|
0 |
|a Technology, Pharmaceutical
|
| 700 |
1 |
|
|a Newman, Ann ,
|e editor
|
| 999 |
|
|
|a 1000169222
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|